2nd November 2018
- 0 comments
Shoosmiths has advised the intermediate capital team of Octopus Investments on its latest growth capital investment, into leading global clinical trial solutions provider Triumph Research Intelligence (TRI).
...In order to read the full story we need you to be registered with us, please click the links below to login or register.